Testing effectiveness (Phase 2)Not Yet RecruitingNCT07482605
What this trial is testing
Furmonertinib Plus Radiotherapy for EGFR+ NSCLC With Pleural Effusion
Who this might be right for
Lung Cancer (NSCLC)Malignant Pleural Effusions (Mpe)- Pleurodesis
Jiangmen Central Hospital 63